Ignite Creation Date:
2024-05-05 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00730665
Status:
TERMINATED
Last Update Posted:
2011-07-14
First Post:
2008-08-06
Brief Title:
Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease GERD
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Parallel-Group Randomized Double-Blind Multi-Center Dose Response Study To Evaluate The Efficacy And Safety Of PF-00885706 A 5-HT4 Receptor Partial Agonist As Add-On Therapy To Esomeprazole For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease GERD Who Have A Poor Response To Proton Pump Inhibitor PPI Treatment
Status:
TERMINATED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study has been placed on clinical hold by the sponsor due to operational reasons
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To understand the dose-response characteristics of PF-00885706 for efficacy in terms of symptomatic relief when used as add-on treatment to esomeprazole 20mg standard proton pump inhibitor PPI treatment in subjects with gastro-esophageal reflux GERD who have inadequate relief with PPIs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None